We Work For Health Maryland

🚨If you haven't seen the @CenterMaryland podcast with @MDPharmacists and @EPICRx about the impact of PBMs on our Maryland pharmacies, and the opportunities in the Lame Duck session of Congress, please check it out.⬇️ centermaryland.org/podcast/center…

From Thermo Fisher Scientific to AstraZeneca, Frederick is a #LifeSciences powerhouse. @fredcochamber CEO, Rick Weldon, writes about Frederick's success stories, and highlights how #MFN policy could affect them: tinyurl.com/nhknvkn7 @RepAprilDelaney

From recent article by CEO of Greater Severna Park and Arnold Chamber of Commerce "If Maryland’s congressional delegation is serious about lowering out-of-pocket costs, it must champion reforms that bring transparency and accountability to the insurance and drug pricing system alike." Meaningful #insurance reforms are needed, for Marylanders and for the U.S. as a whole. #Healthcare #Maryland #ProtectPatients Read more: tinyurl.com/56crk9hv

From recent @thehill article by Rep. Moran: The U.S. depends heavily on #China for key ingredients used in many essential medicines, in some cases up to 80 to 90 percent. This raises real concerns about supply disruptions & long term access to the treatments patients rely on every day. Read more: tinyurl.com/2m7v4cr8 #PatientAccess #Healthcare #DrugSupply

Patients need relief from extreme costs and access barriers imposed by #PharmacyBenefitManagers and their vertically integrated affiliates. @POTUS has the chance to make a real impact for patients. Read more from the Washington Times: tinyurl.com/9zuzd8zm #HealthCare #ProtectPatients #PBMs

Exciting news from Governor Moore: “South Korea’s largest biotech company is opening its first U.S. manufacturing facility here in Maryland. In the state of Maryland, we are delivering for our people and not playing for second.” Continued investment like this depends on continued opposition by our policymakers to government price setting policies like #MostFavoredNation & PDAB's #UpperPaymentLimits. Read more from Gov Moore's announcement: tinyurl.com/SamsungBiologi… @RepRaskin @Sen_Alsobrooks @ChrisVanHollen

We cannot fix healthcare costs & barriers to care without addressing the role of mega insurers. Insurer practices like this must be addressed by policymakers. Read Lorena's healthcare coverage story here: tinyurl.com/mr43uwv3 #HealthCare #Insurance #ProtectPatients @ChrisVanHollen @Sen_Alsobrooks

It's clear that many #340B entities aren't using program dollars for charity care. Between 2014 & 2022, uncompensated care per hospital bed decreased by 51.4% while assets per hospital bed increased by 30.8% in #Maryland. Reform for accountability & transparency is needed now. @Sen_Alsobrooks Learn more: tinyurl.com/mw6j5ckv #HealthCare #ProtectPatients

The #340B program can and should work for patients. It just requires serious reform to ensure that transparency and accountability measures ensure that program benefits reach #patients, not corporate pockets. Read @NCL_Tweets report on aggressive debt collection practices in 340B hospitals: tinyurl.com/NCL340BHospita… #HealthCare @RepJohnnyO @RepKweisiMfume

A new report from the National Consumers League says 340B cancer hospitals are more likely to pursue aggressive debt collection. It's time for accountability reforms in the 340B program. #Healthcare #340B #ProtectPatients Learn more: tinyurl.com/4xfh2yen @Sen_Alsobrooks

Prior authorization, step therapy, restrictive formularies, & narrow networks aren't cost management tools. They're levers to maximize rebate & spread revenue. It's time for serious change to the #insurance industry. Read more here: tinyurl.com/rvay5fvf @RepAndyHarrisMD @RepStenyHoyer #ProtectPatients #HealthCare

Montgomery County celebrated the official launch of HJF Innovation Labs at MontgomeryCountyMD (HIL), a biotech lab space in North Bethesda. Investments like these are crucial to Maryland's life sciences landscape. Maryland's lawmakers must continuously oppose #MostFavoredNation and other price-setting policies to ensure continued investment in the U.S., and right here in #Maryland. @Sen_Alsobrooks Learn more: tinyurl.com/yc5m3x5f

Ahead of tomorrow’s Senate HELP session, Maryland patients are speaking up. We need lower drug costs, not policies that could delay access to new treatments. @sen_alsobrooks please oppose MFN. #ProtectPatients #OpposeMFN #HealthCare

@weworkforhealth warns that enacting MFN could allow other countries to surge ahead of the U.S. in biopharma innovation, posing concerns for patient access and national security. weworkforhealth.org/post/we-work-f… @POTUS @WhiteHouse

If President Trump wants patients to continue to have access to life-saving cures as he stated during the SOTU, MFN is the wrong strategy. Price controls hinder innovation, making novel cures less accessible to patients. Learn more about the potential implications from @weworkforhealth: weworkforhealth.org/post/the-hidde… @POTUS @WhiteHouse

Actions from @FTC & @USDOL are building on Congress’ work to rein in #PBMs and the insurance companies that own them. Washington must keep pressing these vertically integrated middlemen to lower costs and improve accountability. #ProtectPatients @POTUS @WhiteHouse

Codifying #MostFavoredNation would derail U.S. leadership in biopharma & ultimately delay life-saving cures for patients. #MFN #ProtectPatients #Healthcare @POTUS @WhiteHouse

Like #MostFavoredNation price-setting on the federal level, the Maryland Prescription Drug Affordability Board's upper payment limit mechanisms won't lower out-of-pocket drug costs for patients, in fact, they could create new barriers to access. Learn more from Value of Care Coalition's recent Maryland voter survey: tinyurl.com/2ps9btke

Fair access to care for Americans is challenged at every stage by vertically integrated insurers that control all aspects of patients' healthcare journeys. Learn more: tinyurl.com/2p9jmpzw #EndInsuranceAbuse #ProtectPatients @RepAndyHarrisMD @RepStenyHoyer